[go: up one dir, main page]

WO1998002137A1 - Composition in gel form for skin oiliness balancing - Google Patents

Composition in gel form for skin oiliness balancing Download PDF

Info

Publication number
WO1998002137A1
WO1998002137A1 PCT/BR1997/000026 BR9700026W WO9802137A1 WO 1998002137 A1 WO1998002137 A1 WO 1998002137A1 BR 9700026 W BR9700026 W BR 9700026W WO 9802137 A1 WO9802137 A1 WO 9802137A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
skin
agent
composition
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BR1997/000026
Other languages
French (fr)
Inventor
Simoni Chitarra Souza
Luiz Gustavo Martins Matheus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industria e Comercio de Cosmeticos Natura Ltda
Original Assignee
Industria e Comercio de Cosmeticos Natura Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industria e Comercio de Cosmeticos Natura Ltda filed Critical Industria e Comercio de Cosmeticos Natura Ltda
Publication of WO1998002137A1 publication Critical patent/WO1998002137A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Definitions

  • the present invention provides a new composition, in gel form, to be applied to the skin of individuals subjected to skin affections, as acne, pimples and blackheads, caused due to excessive oiliness of the sebaceous secreting glands, with the aim of reducing skin oiliness, maintaining it balanced in relation to cutis optimizing conditions.
  • This gel promotes antiseptic action and mild refreshing sensation when applied to the skin.
  • the invented gel also exhibits a keratolytic action, acting on cellular renovation and capillary and sebaceous follicle clearance.
  • this gel contains active principles acting on skin oiliness regulation, maintaining the skin in an optimized level for the performance of its own functions when directly exposed to the environment, specially the face.
  • the present invention makes the cooperative association of various active principles in mutually optimizing ratios.
  • a renovating agent for cutis cells being this allantoin, added in a 0,05 to 0,50% ratio, by weight, in relation to the global composition.
  • the allantoin favors the cellular proliferation, restoring the affected tissue, calming down irritations and dissipating skin roughness.
  • a specific moisturizing agent being this a sodium PCA, in other words, the sodium PCA salt, a skin moisturizing natural component, v.g. NMF (Natural Moisturizing Factor) moisturizing compound.
  • This component corresponds to 0,10 to 2,00%, by weight, in relation to the global composition.
  • One reinforcing moisturizing agent being this a natural product, namely Aloe vera extract. This component, contributing to cutaneous hydration, efficiently collaborates to the skin anti-inflammatory and restoring scaring action, exerted by the invented gel.
  • This agent corresponds to 0,10 to 0,50%, by weight, in relation to the global composition.
  • a keratolytic agent added in a 0,30 to 2,00% ratio, by weight, in relation to the composition.
  • This agent is salicylic acid, which collaborates to the formation of an unfavorable medium for bacterial proliferation, helping in skin's irritations and inflammations treatment.
  • the Hawthorn extract is also a vegetable extract, being rich in organic acids and natural antioxidants, flavonoids and procyanides, which have a significant action in skin lesions reduction, caused by inflammations and acne.
  • This extract is capable of reducing the Propionibacte um acnes population. Great quantities of this microorganism can be found in the skin subjected to acne affections. This extract collaborates to the inflammatory process reduction and, in association to salicylic acid, mitigates the hyperkeratinization.
  • This oiliness regulating agents association corresponds to composition's 10,00 to 50,00%, by weight.
  • the relative proportion of Hawthorn extract in relation to Cytobiol iris extract varies between 1 :1 and 2:3, by weight.
  • a specially adequate ratio of Hawthorn extract varies between 5,00% to 20,00%, by weight, and between 5,00% to 30,00%, by weight, of Cytobiol iris extract, in relation to the global composition.
  • Cytobiol iris extract is a product extracted from Iris germanica, a complex containing zinc and vitamin A in hydrosoluble forms, having proved favorable action in the bacteriostatic and anti-inflammatory (in case of acne) actuation area and sebaceous secretion regulation.
  • the above listed active substances are formulated in the form of an aqueous gel through usual processing techniques, and can be processed at room temperature, with adjunction of adequate additives, also known by themselves.
  • adjuvant additives form the liquid basis, which acts as vehicle for the active substances dispersion or dissolution, being adjusted to guarantee the physical, chemical and also microbiological formulation stability and a pleasant sensorial when the product is applied to the skin.
  • the formulation can also contain perfume.
  • the referred additives comprise: a) An aqueous vehicle, in a ratio varying between 60,00 to 80,00%, by weight, corresponding to the basis.
  • An antioxidant agent to avoid the deterioration of the substances sensible to the oxygen contained in the air, contributing for composition's chemical stability. This antioxidant is chosen between butyl hydroxytoluene (BHT), butyl hydroxyanisole (BHA), di-alpha-tocopherol and ascorbic acid, added in a ratio varying between 0,01 to 0,10%, by weight, in relation to the basis.
  • BHT butyl hydroxytoluene
  • BHA butyl hydroxyanisole
  • di-alpha-tocopherol and ascorbic acid added in a ratio varying between 0,01 to 0,10%, by weight, in relation to the basis.
  • a thickener agent which corroborates in the aqueous phase gelling, giving the composition a gel consistency.
  • This thickener is at least one component of the group comprising vinyl polymers, as poly(vinyl acetate) and/or poly(vinyl alcohol), acrylics, specially hydrophilic (met)acrylates, gums, starch and modified starches, modified aluminium and magnesium silicates, alkylaryl ammonium compounds, esmectitas, cellulose derivatives, specially cellulosic esters and ethers, fatty alcohols, polyethylene glycol stearates and hydrated aluminium silicates. These agents are added in a 0,10 to 5,00% ratio, by weight, in relation to the basis.
  • vinyl polymers as poly(vinyl acetate) and/or poly(vinyl alcohol), acrylics, specially hydrophilic (met)acrylates, gums, starch and modified starches, modified aluminium and magnesium silicates, alkylaryl ammonium compounds, esmectitas, cellulose derivatives, specially cellulosic esters and ethers, fatty alcohols, poly
  • a solutizing agent of hydroinsoluble or hydrofuge components that is chosen between at least one ethanolic compounds, ethoxylated and/or hydrogenated and/or modified fatty alcohols derivatives, sulphonic alkyl benzene derivatives and dependent. These are added in a ratio varying between 1 ,00 to 15,00%, by weight, in relation to the basis.
  • An humectant agent as glycerols, glycols, sorbitol, hydrosoluble silicones, to facilitate the dispersion of components which are not soluble in the aqueous phase. Its ratio, in relation to the basis, varies between 2,00 to 20,00%, by weight.
  • the first step is the keratolytic agent, namely the salicylic acid, and the antiseptic agent triclosan cold solubilization, in a chosen solutizing agent ratio, for example ethanol or one of its derivatives and/or ethyl ether.
  • a solutizing agent ratio for example ethanol or one of its derivatives and/or ethyl ether.
  • This solution is than incorporated to the vehicle, preferably, already containing the thickener, humectant and antioxidant agents, specially, through mechanical homogenization.
  • Example 1 represents the milder formulation type, to be used for the care of skins little affected by irritations and inflammations.
  • the invention provides a component variation, specially, of the actives described in example 1 , obtaining two complementary formulations, one exhibiting intermediate activity, example 2, for skins more affected by acne and other inflammations, and the other, example 3, of more vigorous action and higher active principles concentration for skins exhibiting high oiliness or deeper skin lesions.
  • example 2 the mentioned active principles are added in a ratio, on the average, 1 ,50 times higher than in example 1.
  • the addition ratios of the active agents: allantoin, sodium PCA and salicylic acid are two times higher than the ones described in example 1
  • the ratios of Aloe vera, Hawthorn and Cytobiol iris extracts are three times higher than the ones described in example 1.
  • the adjuvant components are accordingly adjusted, so that it is possible to obtain an aqueous gel, exhibiting the desired consistency for skin application, without exhibiting free flowing, according to cosmetics laboratory routines.
  • the gels for skin oiliness balancing were submitted to dermatological tests, including primary and cumulative or accumulative dermal irritability evaluations, sensitization, phototoxicity and photoallergy.
  • the invented products were approved in the tests and, thus, considered dermatologist tested and accepted.
  • the invented product received the status of "not comedogenic".
  • a clinical test was conducted to verify the specific action of the invented products, with 12 to 24 years old volunteers. The main objective was to evaluate their efficiency in acne grades I and II incidence and similar skin affections, caused due to excessive oiliness. The obtained results were positive in approximately 2/3 of the examined cases.
  • the application of the present gel in association to the liquid antiseptic soap which is the object of a co-pending request of the same claimant, resulted in a skin oiliness reduction in 92,5% of the volunteers and in lesions number reduction in 65,0% of the examined cases.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a fluid gel for skin care, exhibiting antiseptic action, of keratolytic action, which promotes gentle refreshing sensation when applied to the skin. It is constituted of a new active substances set, each one of them providing a specific action, namely: a renovating agent, allantoin, a moisturizing agent, sodium PCA, a skin restoring agent, Aloe vera extract, a keratolytic agent, salicylic acid, an antiseptic agent, triclosan, two skin oiliness regulation agents, Hawthorn extract and Cytobiol iris extract, which cooperate in skin oiliness regulation, controlling secretion excess and, or sebaceous glands or follicle obstruction, avoiding skin irritations. These active substances are formulated with usual additives, that are dissolved and/or dispersed in an aqueous vehicle, thickened through usual techniques so as to form a gel with adequate consistency and stability. The present gel is specially indicated for use together with a liquid antiseptic soap, which is the object of a co-pending request of the same claimant.

Description

"COMPOSITION IN GEL FORM FOR SKIN OILINESS BALANCING".
Description
The present invention provides a new composition, in gel form, to be applied to the skin of individuals subjected to skin affections, as acne, pimples and blackheads, caused due to excessive oiliness of the sebaceous secreting glands, with the aim of reducing skin oiliness, maintaining it balanced in relation to cutis optimizing conditions.
This gel, according to the invention, promotes antiseptic action and mild refreshing sensation when applied to the skin. As in the above mentioned affections it is necessary to remove the secreted products and inactive cells residues, the invented gel also exhibits a keratolytic action, acting on cellular renovation and capillary and sebaceous follicle clearance. Particularly, this gel contains active principles acting on skin oiliness regulation, maintaining the skin in an optimized level for the performance of its own functions when directly exposed to the environment, specially the face.
In order to substantiate the multiple action of this gel, the present invention makes the cooperative association of various active principles in mutually optimizing ratios.
These active principles, characterizing the present composition, are:
1 ) A renovating agent for cutis cells, being this allantoin, added in a 0,05 to 0,50% ratio, by weight, in relation to the global composition. The allantoin favors the cellular proliferation, restoring the affected tissue, calming down irritations and dissipating skin roughness.
2) A specific moisturizing agent, being this a sodium PCA, in other words, the sodium PCA salt, a skin moisturizing natural component, v.g. NMF (Natural Moisturizing Factor) moisturizing compound. This component corresponds to 0,10 to 2,00%, by weight, in relation to the global composition. 3) One reinforcing moisturizing agent, being this a natural product, namely Aloe vera extract. This component, contributing to cutaneous hydration, efficiently collaborates to the skin anti-inflammatory and restoring scaring action, exerted by the invented gel. This agent corresponds to 0,10 to 0,50%, by weight, in relation to the global composition. 4) A keratolytic agent, added in a 0,30 to 2,00% ratio, by weight, in relation to the composition. This agent is salicylic acid, which collaborates to the formation of an unfavorable medium for bacterial proliferation, helping in skin's irritations and inflammations treatment.
5) A surface antiseptic, of specific bacteriostatic action, being this triclosan, added in a 0,05 to 0,50% ratio, by weight, in relation to the global composition. 6) An association of two skin oiliness regulating agents, being them, respectively, Hawthorn extract and Cytobiol iris vegetable extract. The Hawthorn extract is also a vegetable extract, being rich in organic acids and natural antioxidants, flavonoids and procyanides, which have a significant action in skin lesions reduction, caused by inflammations and acne. This extract is capable of reducing the Propionibacte um acnes population. Great quantities of this microorganism can be found in the skin subjected to acne affections. This extract collaborates to the inflammatory process reduction and, in association to salicylic acid, mitigates the hyperkeratinization.
This oiliness regulating agents association corresponds to composition's 10,00 to 50,00%, by weight. In this association, the relative proportion of Hawthorn extract in relation to Cytobiol iris extract varies between 1 :1 and 2:3, by weight. A specially adequate ratio of Hawthorn extract varies between 5,00% to 20,00%, by weight, and between 5,00% to 30,00%, by weight, of Cytobiol iris extract, in relation to the global composition. Cytobiol iris extract is a product extracted from Iris germanica, a complex containing zinc and vitamin A in hydrosoluble forms, having proved favorable action in the bacteriostatic and anti-inflammatory (in case of acne) actuation area and sebaceous secretion regulation.
Formulation
The above listed active substances are formulated in the form of an aqueous gel through usual processing techniques, and can be processed at room temperature, with adjunction of adequate additives, also known by themselves.
These adjuvant additives form the liquid basis, which acts as vehicle for the active substances dispersion or dissolution, being adjusted to guarantee the physical, chemical and also microbiological formulation stability and a pleasant sensorial when the product is applied to the skin. If desired, the formulation can also contain perfume.
The referred additives comprise: a) An aqueous vehicle, in a ratio varying between 60,00 to 80,00%, by weight, corresponding to the basis. b) An antioxidant agent, to avoid the deterioration of the substances sensible to the oxygen contained in the air, contributing for composition's chemical stability. This antioxidant is chosen between butyl hydroxytoluene (BHT), butyl hydroxyanisole (BHA), di-alpha-tocopherol and ascorbic acid, added in a ratio varying between 0,01 to 0,10%, by weight, in relation to the basis. c) A thickener agent, which corroborates in the aqueous phase gelling, giving the composition a gel consistency. This thickener is at least one component of the group comprising vinyl polymers, as poly(vinyl acetate) and/or poly(vinyl alcohol), acrylics, specially hydrophilic (met)acrylates, gums, starch and modified starches, modified aluminium and magnesium silicates, alkylaryl ammonium compounds, esmectitas, cellulose derivatives, specially cellulosic esters and ethers, fatty alcohols, polyethylene glycol stearates and hydrated aluminium silicates. These agents are added in a 0,10 to 5,00% ratio, by weight, in relation to the basis. d) A solutizing agent of hydroinsoluble or hydrofuge components, that is chosen between at least one ethanolic compounds, ethoxylated and/or hydrogenated and/or modified fatty alcohols derivatives, sulphonic alkyl benzene derivatives and dependent. These are added in a ratio varying between 1 ,00 to 15,00%, by weight, in relation to the basis. e) An humectant agent, as glycerols, glycols, sorbitol, hydrosoluble silicones, to facilitate the dispersion of components which are not soluble in the aqueous phase. Its ratio, in relation to the basis, varies between 2,00 to 20,00%, by weight. Preferably, during the gel preparation, the first step is the keratolytic agent, namely the salicylic acid, and the antiseptic agent triclosan cold solubilization, in a chosen solutizing agent ratio, for example ethanol or one of its derivatives and/or ethyl ether. This solution is than incorporated to the vehicle, preferably, already containing the thickener, humectant and antioxidant agents, specially, through mechanical homogenization.
Following some typical examples, which should not be considered as delimiting, because is obvious the possibility of substituting the agents listed in the examples by others, already above described, as also varying the respective ratios within the above mentioned limits, as it is usual in cosmetology.
Example 1
As typical example, we have a fluid gel, sufficiently thickened so that it does not exhibit free flowing, whose active part is comprised of: 0,25%, by weight, of allantoin, renovating,
0,75%, by weight, of sodium PCA, moisturizing,
0,25%, by weight, of cooperative moisturizer, which is Aloe vera extract,
0,80%, by weight, of salicylic acid, keratolytic,
0,25%, by weight, of triclosan, antiseptic, 6,20%, by weight, of oiliness regulator, which is Hawthorn extract,
6,50%, by weight, of Cytobiol iris extract, reinforcing oiliness regulating agent. This active part of the formulation, totalizing 15,00%, by weight, is dissolved/dispersed in a vehicle containing additives, totalizing 85%, comprising: 0,05%, by weight, of ascorbic acid as antioxidant, 9,95%, by weight, of ethanolic solutizer, 3,00%, by weight, of thickener constituted of poly(vinyl acetate) with a 60% acetylation grade and 8,00%, by weight, of hydrosoluble silicone, in a corresponding distilled or demineralized water quantity necessary to complete composition's 100,00%, by weight. Examples 2 and 3
Example 1 represents the milder formulation type, to be used for the care of skins little affected by irritations and inflammations. The invention provides a component variation, specially, of the actives described in example 1 , obtaining two complementary formulations, one exhibiting intermediate activity, example 2, for skins more affected by acne and other inflammations, and the other, example 3, of more vigorous action and higher active principles concentration for skins exhibiting high oiliness or deeper skin lesions.
Thus, in example 2, the mentioned active principles are added in a ratio, on the average, 1 ,50 times higher than in example 1.
In example 3, the addition ratios of the active agents: allantoin, sodium PCA and salicylic acid are two times higher than the ones described in example 1 , while the ratios of Aloe vera, Hawthorn and Cytobiol iris extracts are three times higher than the ones described in example 1. To complete formulations 2 and 3, the adjuvant components are accordingly adjusted, so that it is possible to obtain an aqueous gel, exhibiting the desired consistency for skin application, without exhibiting free flowing, according to cosmetics laboratory routines.
Of course it is also possible to make other variations in the invented gel composition, attaining the respective above mentioned limits.
Conducted Tests
The gels for skin oiliness balancing, related to this invention, were submitted to dermatological tests, including primary and cumulative or accumulative dermal irritability evaluations, sensitization, phototoxicity and photoallergy. The invented products were approved in the tests and, thus, considered dermatologist tested and accepted.
In the conducted comedogenicity test, the invented product received the status of "not comedogenic". A clinical test was conducted to verify the specific action of the invented products, with 12 to 24 years old volunteers. The main objective was to evaluate their efficiency in acne grades I and II incidence and similar skin affections, caused due to excessive oiliness. The obtained results were positive in approximately 2/3 of the examined cases. However, the application of the present gel in association to the liquid antiseptic soap, which is the object of a co-pending request of the same claimant, resulted in a skin oiliness reduction in 92,5% of the volunteers and in lesions number reduction in 65,0% of the examined cases.
Thus, it is possible to verify that the present invention product attains the collimated results.

Claims

1. Composition in gel form, for skin oiliness balancing, with sebum secretion control in the sebaceous follicle, promoting its clearance, and skin moisturizing and cellular renovation, with improvement of skin aspect, characterized by the fact of containing 10,51 to 55,50%, by weight, of an active components set, constituted of:
0,05 to 0,50%, by weight, of allantoin, as skin renovating agent, 0,10 to 2,00%, by weight, of sodium PCA, as skin moisturizing agent, 0,01 to 0,50%, by weight, of Aloe vera extract, exhibiting skin moisturizing and restoring action,
0,30 to 2,00%, by weight, of salicylic acid, as keratolytic agent, 0,05 to 0,50%, by weight, of triclosan, as antiseptic agent, 5,00 to 20,00%, by weight, of Hawthorn extract, exhibiting skin oiliness regulating action, and
5,00 to 30,00%, by weight, of a cooperative agent for skin oiliness regulation, which is the Cytobiol iris extract, being the remaining to complete composition's 100,00%, by weight, constituted of a vehicle, exhibiting the consistency of a fluid gel, water based, containing complementary agents, so as to give the composition the adequate consistency, stability and pleasant sensorial when applied to the skin, being them antioxidant agents, thickener, solutizer and humectant.
2. Composition in gel form, according to vindication 1 , characterized by the fact of comprising 0,01 to 0,10%, by weight, of at least one antioxidant agent, chosen between butyl hydroxytoluene (BHT), butyl hydroxyanisole (BHA), di-alpha-tocopherol, ascorbic acid.
3. Composition in gel form, according to vindication 1 , characterized by the fact of comprising 0,10 to 5,00%, by weight, of at least one thickener agent, chosen between vinyl polymers, acrylic, gums, starch and modified starches, modified aluminium and magnesium silicates, alkylaryl ammonium compounds, esmectitas, cellulose derivatives, specially their esters and ethers, fatty alcohols, polyethylene glycol stearates and hydrated aluminium silicates.
4. Composition in gel form, according to vindication 1 , characterized by the fact of comprising 1 ,00 to 15,00%, by weight, of at least one solutizing agent, chosen between ethanolic compounds, ethoxylated fatty alcohols derivatives and alkyl benzene derivatives and dependents.
5. Composition in gel form, according to vindication 1 , characterized by the fact of comprising 2,00 to 20,00%, by weight, of at least one humectant agent, chosen between glycerols, glycols, sorbitol, hydrosoluble silicones.
PCT/BR1997/000026 1996-07-12 1997-07-10 Composition in gel form for skin oiliness balancing Ceased WO1998002137A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI9603086-0 1996-07-12
BR9603086A BR9603086A (en) 1996-07-12 1996-07-12 Gel-shaped composition to balance skin oiliness

Publications (1)

Publication Number Publication Date
WO1998002137A1 true WO1998002137A1 (en) 1998-01-22

Family

ID=4064626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR1997/000026 Ceased WO1998002137A1 (en) 1996-07-12 1997-07-10 Composition in gel form for skin oiliness balancing

Country Status (5)

Country Link
AR (1) AR007870A1 (en)
BR (1) BR9603086A (en)
CO (1) CO5300391A1 (en)
PE (1) PE95998A1 (en)
WO (1) WO1998002137A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043205A1 (en) * 1998-02-26 1999-09-02 Pro-Ren A/S Gel-type disinfectant having a low alcohol content
FR2777185A1 (en) * 1998-04-08 1999-10-15 Serobiologiques Lab Sa Cosmetic and/or pharmaceutical composition for treating wrinkles
WO2003028762A1 (en) * 2001-09-28 2003-04-10 Ethicon, Inc. Novel antimicrobial resistance blocking compositions
WO2005023207A1 (en) * 2003-09-10 2005-03-17 Unilever Plc Method of decreasing sebum production
CN106176542A (en) * 2016-08-26 2016-12-07 樊之雄 A kind of moisturizing defying age honeydew and preparation method thereof
EP3369459A1 (en) * 2017-03-01 2018-09-05 The Boots Company PLC Kit of cosmetic skincare compositions
CN114533809A (en) * 2022-03-02 2022-05-27 北京鲁齐生物科技有限公司 Vitamin E antibacterial cream and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011780A1 (en) * 1991-12-09 1993-06-24 Royale Renaissance, Inc. Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed
WO1993021899A1 (en) * 1992-05-05 1993-11-11 The Procter & Gamble Company Acne treating composition
JPH07157415A (en) * 1993-12-03 1995-06-20 Shiseido Co Ltd Hair cosmetic

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011780A1 (en) * 1991-12-09 1993-06-24 Royale Renaissance, Inc. Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed
WO1993021899A1 (en) * 1992-05-05 1993-11-11 The Procter & Gamble Company Acne treating composition
JPH07157415A (en) * 1993-12-03 1995-06-20 Shiseido Co Ltd Hair cosmetic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 95, no. 009 (C - ) *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043205A1 (en) * 1998-02-26 1999-09-02 Pro-Ren A/S Gel-type disinfectant having a low alcohol content
US6627207B1 (en) 1998-02-26 2003-09-30 Pro-Ren A/S Water-based, quick-drying, gel-type disinfectant having low alcohol content
FR2777185A1 (en) * 1998-04-08 1999-10-15 Serobiologiques Lab Sa Cosmetic and/or pharmaceutical composition for treating wrinkles
WO2003028762A1 (en) * 2001-09-28 2003-04-10 Ethicon, Inc. Novel antimicrobial resistance blocking compositions
WO2005023207A1 (en) * 2003-09-10 2005-03-17 Unilever Plc Method of decreasing sebum production
CN106176542A (en) * 2016-08-26 2016-12-07 樊之雄 A kind of moisturizing defying age honeydew and preparation method thereof
EP3369459A1 (en) * 2017-03-01 2018-09-05 The Boots Company PLC Kit of cosmetic skincare compositions
WO2018157976A1 (en) * 2017-03-01 2018-09-07 The Boots Company Plc Kit of cosmetic skincare compositions
CN110430862A (en) * 2017-03-01 2019-11-08 布茨公司 Cosmetic skin care composition box set
CN114533809A (en) * 2022-03-02 2022-05-27 北京鲁齐生物科技有限公司 Vitamin E antibacterial cream and preparation method thereof

Also Published As

Publication number Publication date
BR9603086A (en) 1998-05-05
PE95998A1 (en) 1998-12-15
AR007870A1 (en) 1999-11-24
CO5300391A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
US4387107A (en) Stable benzoyl peroxide composition
AU605349B2 (en) Anti-acne composition
US5614201A (en) Cosmetic composition for treatment of pimples and redness
US5415861A (en) Composition and method for visibly reducing the size of skin pores
US5720963A (en) Barrier disruption treatments for structurally deteriorated skin
US4540567A (en) Cosmetic composition
JP4286451B2 (en) Skin care composition with improved skin hydration
US4454118A (en) Method of treating psoriasis
AU5990396A (en) Topical vehicles containing solubilized and stabilized azelaic acid
IE903509A1 (en) Tretinoin emulsified cream formulations of improved¹stability
EP0606197B1 (en) Use of aromatic benzoates as personal deodorants
US4294823A (en) Astringent or degreasing lotion
US3867522A (en) Acne composition
WO1998002137A1 (en) Composition in gel form for skin oiliness balancing
AU2004240615A1 (en) Topical treatment of sebum related skin conditions
KR102463133B1 (en) Cosmetic Composition Containing High-Content of Urea
EP0957895A1 (en) Shaving composition and method for preventing pseudofolliculitis barbae
AU9742301A (en) Treatment for skin
WO2013092872A2 (en) Cosmetic processes with glucosamine-based hydrogels
Haroun Dry skin in the elderly
KR20020075632A (en) Cosmetic for preventing and treating acnes containing Cryptotanshinone
WO1998002139A1 (en) Liquid antiseptic soap for skin care
CA2556810A1 (en) Skincare compositions comprising salicylic acid
JP2008184444A (en) Adapalene-containing external preparation composition
CN116869863A (en) Oil-control pre-makeup isolation emulsion and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA MX US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase